Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Cancer Genetics and Cytogenetics|September 15, 2005
GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesisS Piaskowski, P Rieske, M Szybka, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2M A Bednarek, S Y Sauma, M C Gammon, et al.The British Journal of Dermatology|August 19, 2007
Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemiaE Robak, D Jesionek-Kupnicka, T Robak, et al.Journal of Immunological Methods|May 17, 1991
Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytesM A Bednarek, S A Engl, M C Gammon, et al.Journal of Medicinal Chemistry|August 27, 2015
Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A AnaloguesAndrew T Bockus, Joshua A Schwochert, Cameron R Pye, et al.Polish Journal of Microbiology|June 24, 2010
Repetitive extragenic palindromic PCR (REP-PCR) as an alternative method for detection of bulking in activated sludgeDagna A Sołtysik, Ilona A Bednarek, Tomasz M Loch, et al.European Review for Medical and Pharmacological Sciences|January 28, 2016
Correlation between depression and burden observed in informal caregivers of people suffering from dementia with time spent on caregiving and dementia severityA Bednarek, E Mojs, A Krawczyk-Wasielewska, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1992
Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2K C Parker, M A Bednarek, L K Hull, et al.Peptides|March 26, 2013
Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwenaJefferson D Revell, Per-Eric Lund, John E Linley, et al.International Journal of Peptide and Protein Research|May 1, 1993
Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological propertiesR L Tolman, M A Bednarek, B A Johnson, et al.Pageof 9